These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32457980)

  • 1. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
    Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
    J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
    [No Abstract]   [Full Text] [Related]  

  • 2. Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?
    Mehta S; Bhandari S; Mehta S
    J Glob Antimicrob Resist; 2020 Sep; 22():864-865. PubMed ID: 32777441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness.
    Al-Kofahi M; Jacobson P; Boulware DR; Matas A; Kandaswamy R; Jaber MM; Rajasingham R; Young JH; Nicol MR
    Clin Pharmacol Ther; 2020 Oct; 108(4):766-769. PubMed ID: 32344449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
    Shehab N; Lovegrove M; Budnitz DS
    JAMA Intern Med; 2020 Oct; 180(10):1384-1386. PubMed ID: 32628242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
    Kara E; Demirkan K; Unal S
    Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
    Principi N; Esposito S
    Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies.
    Al-Tawfiq JA; Memish ZA
    Int J Antimicrob Agents; 2020 May; 55(5):105968. PubMed ID: 32259576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Rathi S; Ish P; Kalantri A; Kalantri S
    Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
    [No Abstract]   [Full Text] [Related]  

  • 10. Audio Interview: Diagnosis and Early Treatment of Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jun; 382(23):e103. PubMed ID: 32492326
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
    Marouf BH; Dizaye K
    Drug Discov Ther; 2020; 14(3):109-116. PubMed ID: 32669519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infection also occurs in patients taking hydroxychloroquine.
    Lahouati M; Mériglier E; Martin L; Bouchet S; Desclaux A; Bonnet F
    J Antimicrob Chemother; 2020 Jul; 75(7):2014-2015. PubMed ID: 32417904
    [No Abstract]   [Full Text] [Related]  

  • 13. Data Analysis of Infection Rates Among Exposed Healthcare Workers Could Reveal Effective Prophylactics Against SARS-CoV-2.
    Núñez-Mujica G; Kichuk T; Carrasco-López C
    Adv Exp Med Biol; 2020; 1288():1-3. PubMed ID: 32424489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed.
    Tahiri Joutei Hassani R; Bennis A
    J Infect Public Health; 2020 Jun; 13(6):865-867. PubMed ID: 32451259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
    Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies to control COVID-19 and future pandemics in Africa and around the globe.
    Fanidi A; Jouven X; Gaye B
    Eur Heart J; 2020 Nov; 41(41):3973-3975. PubMed ID: 32255477
    [No Abstract]   [Full Text] [Related]  

  • 19. Rising to the Challenge: Otolaryngologists in the COVID-19 Pandemic.
    Patel ZM
    Otolaryngol Clin North Am; 2020 Dec; 53(6):xxvii-xxviii. PubMed ID: 33127044
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing Armed Forces recruits for COVID-19.
    Norheim AJ; Nakstad E; Berg AS; Borud EK; Rein E
    Tidsskr Nor Laegeforen; 2020 Jun; 140(10):. PubMed ID: 32602333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.